Get startedLog in
    Picture of Richter Gedeon Vegyeszeti Gyar Nyrt logo

    RICHTER — Richter Gedeon Vegyeszeti Gyar Nyrt News Story

    0.000.00%
    hu flag iconLast trade - 00:00
    HealthcareConservativeLarge CapSuper Stock
    All News

    Brief: FDA has granted 6-month additional exclusivity for Cariprazine in US, Richter says

    Picture of Richter Gedeon Vegyeszeti Gyar Nyrt logoRichter Gedeon Vegyeszeti Gyar Nyrt
    15/12/2025 07:07
    Dec 15 (Reuters) - Richter Gedeon Nyrt GDRB.BU says in a statement on the Budapest Stock Exchange website:

HUNGARY RICHTER SAYS FDA HAS GRANTED 6-MONTH ADDITIONAL EXCLUSIVITY FOR CARIPRAZINE IN THE US

THIS EXPIRES 17 MARCH 2030

Source text: [ID:]

Further company coverage: GDRB.BU

 (Reporting by Krisztina  Than)

 ((Krisztina.Than@thomsonreuters.com;))

    Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt

    See all news